OrthoPediatrics Corp Quarterly Balance Sheets Chart
Quarterly
|
Annual
OrthoPediatrics Corp Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||||||||||
| cash | 44,553,000 | 33,439,000 | 43,820,000 | 8,991,000 | 35,423,000 | 88,372,000 | 113,054,000 | 53,580,000 | 70,777,000 | 19,669,000 | 21,858,000 | 52,774,000 | 60,691,000 | 24,463,000 | 26,506,000 | 34,591,000 | 42,582,000 | 2,238,000 | ||||||||||||||
| restricted cash | 2,052,000 | 1,990,000 | 1,957,000 | 1,998,000 | 1,963,000 | 1,962,000 | 1,972,000 | 1,592,000 | 1,596,000 | 1,481,000 | 1,471,000 | 1,449,000 | 1,357,000 | 1,363,000 | 1,365,000 | 1,368,000 | 1,371,000 | 1,369,000 | 1,374,000 | 1,369,000 | 1,361,000 | 1,361,000 | 1,250,000 | |||||||||
| short-term investments | 25,596,000 | 25,333,000 | 25,013,000 | 25,017,000 | 26,141,000 | 71,780,000 | 83,472,000 | 73,074,000 | ||||||||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,410 and 1,145, respectively | 53,797,000 | |||||||||||||||||||||||||||||||
| inventories | 125,265,000 | 119,752,000 | 117,005,000 | 120,934,000 | 116,366,000 | 112,689,000 | 105,851,000 | 100,533,000 | 90,983,000 | 84,922,000 | 78,192,000 | 74,041,000 | 67,484,000 | 64,077,000 | 57,569,000 | 55,458,000 | 56,376,000 | 55,266,000 | 52,989,000 | 52,032,000 | 48,875,000 | 43,966,000 | 38,000,000 | 34,533,000 | 32,855,000 | 28,081,000 | 25,541,000 | 26,646,000 | 24,816,000 | 22,004,000 | 19,498,000 | 18,434,000 |
| prepaid expenses and other current assets | 6,439,000 | 7,552,000 | 7,021,000 | 6,489,000 | 4,499,000 | 5,056,000 | 3,750,000 | 3,980,000 | 3,642,000 | 4,005,000 | 3,966,000 | 2,751,000 | 2,712,000 | 3,048,000 | 3,229,000 | 2,745,000 | 2,471,000 | 1,884,000 | 2,618,000 | 2,065,000 | 1,534,000 | 1,514,000 | 1,464,000 | 1,623,000 | 1,277,000 | 1,452,000 | 1,256,000 | 1,045,000 | 1,063,000 | 1,114,000 | 831,000 | 615,000 |
| total current assets | 257,702,000 | 232,059,000 | 237,173,000 | 248,312,000 | 193,783,000 | 203,725,000 | 226,496,000 | 226,172,000 | 223,255,000 | 224,976,000 | 226,719,000 | 224,558,000 | 148,148,000 | 131,424,000 | 133,648,000 | 135,459,000 | 145,388,000 | 152,028,000 | 158,429,000 | 161,378,000 | 180,377,000 | 115,121,000 | 128,058,000 | 108,720,000 | 106,843,000 | 93,111,000 | 97,156,000 | 61,844,000 | 62,735,000 | 65,949,000 | 69,561,000 | 28,891,000 |
| property and equipment | 52,928,000 | 52,622,000 | 50,596,000 | 54,765,000 | 53,482,000 | 48,721,000 | 41,048,000 | 40,236,000 | 40,071,000 | 36,916,000 | 34,286,000 | 36,313,000 | 36,601,000 | 31,068,000 | 28,515,000 | 28,783,000 | 28,242,000 | 28,342,000 | 27,227,000 | 24,275,000 | 24,131,000 | 24,078,000 | 21,349,000 | 21,532,000 | 20,915,000 | 16,789,000 | 12,768,000 | 12,774,000 | 12,770,000 | 12,280,000 | 10,391,000 | 9,749,000 |
| other assets: | ||||||||||||||||||||||||||||||||
| amortizable intangible assets | 62,950,000 | 62,348,000 | 64,427,000 | 65,955,000 | 67,848,000 | 70,382,000 | 69,275,000 | 69,513,000 | 71,932,000 | 64,642,000 | 64,980,000 | 66,285,000 | 58,777,000 | 53,476,000 | 55,494,000 | 54,904,000 | 50,552,000 | 50,901,000 | 50,284,000 | 48,898,000 | 42,206,000 | 15,121,000 | 14,484,000 | 10,200,000 | 10,458,000 | 1,846,000 | 1,921,000 | 2,000,000 | 2,080,000 | 2,154,000 | 2,089,000 | 2,183,000 |
| goodwill | 99,019,000 | 93,673,000 | 93,844,000 | 91,262,000 | 90,512,000 | 91,481,000 | 83,699,000 | 80,894,000 | 82,911,000 | 84,127,000 | 86,821,000 | 88,044,000 | 71,707,000 | 70,987,000 | 72,349,000 | 70,490,000 | 69,656,000 | 68,463,000 | 70,511,000 | 60,148,000 | 68,420,000 | 15,179,000 | 26,183,000 | 10,732,000 | 10,971,000 | |||||||
| other intangible assets | 17,082,000 | 16,736,000 | 16,752,000 | 18,744,000 | 18,669,000 | 18,792,000 | 15,287,000 | 15,008,000 | 16,087,000 | 15,629,000 | 14,921,000 | 14,854,000 | 15,708,000 | 14,040,000 | 14,268,000 | 13,957,000 | 13,817,000 | 13,618,000 | 13,961,000 | 13,305,000 | 13,357,000 | 4,700,000 | 4,490,000 | 2,240,000 | 2,170,000 | 260,000 | 260,000 | 260,000 | 260,000 | 260,000 | 260,000 | 260,000 |
| other non-current assets | 13,925,000 | 12,812,000 | 10,417,000 | 10,256,000 | 6,467,000 | 4,084,000 | 2,940,000 | 621,000 | 614,000 | |||||||||||||||||||||||
| total other assets | 192,976,000 | 185,569,000 | 185,440,000 | 186,217,000 | 183,496,000 | 184,739,000 | 171,201,000 | 166,036,000 | 171,544,000 | 164,398,000 | 166,722,000 | 169,183,000 | 146,192,000 | 138,503,000 | 142,111,000 | 139,351,000 | 134,025,000 | 132,982,000 | 134,756,000 | 122,351,000 | 123,983,000 | 35,000,000 | 45,157,000 | 23,172,000 | 23,674,000 | 2,106,000 | 2,181,000 | 2,260,000 | 2,340,000 | 2,414,000 | 2,349,000 | 2,443,000 |
| total assets | 503,606,000 | 470,250,000 | 473,209,000 | 489,294,000 | 430,761,000 | 437,185,000 | 438,745,000 | 432,444,000 | 434,870,000 | 426,290,000 | 427,727,000 | 430,054,000 | 330,941,000 | 300,995,000 | 304,274,000 | 303,593,000 | 307,655,000 | 313,352,000 | 320,412,000 | 308,004,000 | 328,491,000 | 174,199,000 | 194,564,000 | 153,424,000 | 151,432,000 | 112,006,000 | 112,105,000 | 76,878,000 | 77,845,000 | 80,643,000 | 82,301,000 | 41,083,000 |
| liabilities and stockholders' equity | ||||||||||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||||||||||
| accounts payable - trade | 12,687,000 | 14,199,000 | 8,908,000 | 11,647,000 | 17,002,000 | 19,736,000 | 12,649,000 | 22,587,000 | 20,890,000 | 16,692,000 | 11,150,000 | 10,881,000 | 14,591,000 | 14,578,000 | 9,325,000 | 8,972,000 | 10,142,000 | 12,009,000 | 10,038,000 | 6,904,000 | 6,003,000 | 8,262,000 | 6,467,000 | 7,746,000 | 6,000,000 | 6,344,000 | 3,971,000 | 5,903,000 | 5,455,000 | 7,197,000 | 5,495,000 | 5,102,000 |
| accrued compensation and benefits | 13,398,000 | 11,325,000 | 13,888,000 | 13,221,000 | 12,616,000 | 9,772,000 | 11,325,000 | 8,671,000 | 8,159,000 | 6,242,000 | 6,744,000 | 6,323,000 | 6,087,000 | 4,433,000 | 5,351,000 | 4,655,000 | 5,651,000 | 4,850,000 | 4,540,000 | 4,772,000 | 4,501,000 | 2,977,000 | 4,349,000 | 3,858,000 | 4,011,000 | 2,670,000 | 3,552,000 | 3,302,000 | 3,237,000 | 2,313,000 | 2,905,000 | 2,288,000 |
| current portion of long-term debt with affiliate | 164,000 | 162,000 | 160,000 | 158,000 | 156,000 | 154,000 | 152,000 | 150,000 | 148,000 | 146,000 | 144,000 | 143,000 | 141,000 | 139,000 | 137,000 | 136,000 | 134,000 | 132,000 | 131,000 | 129,000 | 128,000 | 126,000 | 124,000 | 123,000 | 121,000 | 120,000 | 118,000 | 117,000 | 115,000 | 114,000 | 113,000 | 111,000 |
| current portion of acquisition installment payable | 610,000 | 1,368,000 | 1,347,000 | 1,325,000 | 1,304,000 | 10,368,000 | 10,149,000 | 9,937,000 | 9,713,000 | 8,000,000 | 7,815,000 | 7,630,000 | 7,445,000 | 12,934,000 | 12,862,000 | 12,791,000 | 12,683,000 | 12,496,000 | 12,233,000 | 11,920,000 | 11,485,000 | |||||||||||
| other current liabilities | 11,807,000 | 10,451,000 | 9,659,000 | 8,274,000 | 8,491,000 | 5,790,000 | 7,391,000 | 6,582,000 | 5,401,000 | 4,138,000 | 5,018,000 | 3,769,000 | 2,949,000 | 2,249,000 | 2,040,000 | 1,464,000 | 1,719,000 | 1,886,000 | 1,744,000 | 2,022,000 | 2,654,000 | 2,467,000 | 2,723,000 | 1,372,000 | 1,537,000 | 1,689,000 | 1,576,000 | 1,594,000 | 1,683,000 | 946,000 | 954,000 | 2,915,000 |
| total current liabilities | 38,666,000 | 37,505,000 | 33,962,000 | 34,625,000 | 39,569,000 | 45,820,000 | 41,666,000 | 47,927,000 | 44,311,000 | 35,218,000 | 30,871,000 | 28,746,000 | 31,213,000 | 34,333,000 | 29,715,000 | 28,018,000 | 30,329,000 | 36,623,000 | 35,028,000 | 25,747,000 | 24,771,000 | 13,832,000 | 13,663,000 | 46,184,000 | 42,187,000 | 10,823,000 | 9,217,000 | 10,916,000 | 10,490,000 | 10,570,000 | 9,467,000 | 10,416,000 |
| long-term liabilities: | ||||||||||||||||||||||||||||||||
| long-term term loan | 47,942,000 | 24,013,000 | 23,957,000 | 23,948,000 | ||||||||||||||||||||||||||||
| long-term convertible note | 48,168,000 | 48,040,000 | 47,913,000 | 47,831,000 | ||||||||||||||||||||||||||||
| long-term debt with affiliate, net of current portion | 368,000 | 410,000 | 451,000 | 491,000 | 532,000 | 572,000 | 611,000 | 650,000 | 688,000 | 725,000 | 763,000 | 799,000 | 31,836,000 | 872,000 | 907,000 | 942,000 | 977,000 | 1,011,000 | 1,044,000 | 1,078,000 | 21,017,000 | 21,043,000 | 26,067,000 | 21,090,000 | 21,112,000 | 21,134,000 | 21,156,000 | 21,330,000 | 21,360,000 | 21,389,000 | 21,418,000 | 19,986,000 |
| other long-term debt, net of current portion | 526,000 | 563,000 | 635,000 | 244,000 | ||||||||||||||||||||||||||||
| acquisition installment payable, net of current portion | 224,000 | 2,493,000 | 2,452,000 | 2,412,000 | 2,371,000 | 3,613,000 | 3,551,000 | 3,489,000 | 3,427,000 | 8,215,000 | 8,019,000 | 7,822,000 | 7,626,000 | 14,690,000 | 14,309,000 | 13,927,000 | 13,546,000 | 13,165,000 | 12,784,000 | 12,402,000 | 12,021,000 | |||||||||||
| deferred income taxes | 3,525,000 | 3,389,000 | 3,381,000 | 4,025,000 | 4,739,000 | 5,202,000 | 5,483,000 | 5,492,000 | 5,564,000 | 6,022,000 | 5,954,000 | 5,457,000 | 6,280,000 | 4,335,000 | 4,771,000 | 4,848,000 | 5,060,000 | 5,233,000 | 5,755,000 | |||||||||||||
| other long-term liabilities | 8,673,000 | 6,691,000 | 5,892,000 | 4,799,000 | 3,007,000 | 1,815,000 | 1,112,000 | 557,000 | 562,000 | 645,000 | 492,000 | 440,000 | 300,000 | 241,000 | 293,000 | 320,000 | 292,000 | 315,000 | 323,000 | 332,000 | 120,000 | 57,000 | 45,000 | |||||||||
| total long-term liabilities | 109,426,000 | 85,599,000 | 84,681,000 | 83,750,000 | 19,899,000 | 20,781,000 | 20,054,000 | 10,188,000 | 10,247,000 | 17,917,000 | 18,208,000 | 17,978,000 | 72,512,000 | 51,618,000 | 49,190,000 | 54,457,000 | 55,725,000 | 54,584,000 | 50,616,000 | 42,821,000 | 61,258,000 | 21,100,000 | 38,540,000 | 21,135,000 | 21,163,000 | 21,134,000 | 21,156,000 | 25,277,000 | 25,298,000 | 25,319,000 | 25,339,000 | 27,486,000 |
| total liabilities | 148,092,000 | 123,104,000 | 118,643,000 | 118,375,000 | 59,468,000 | 66,601,000 | 61,720,000 | 58,115,000 | 54,558,000 | 53,135,000 | 49,079,000 | 46,724,000 | 103,725,000 | 85,951,000 | 78,905,000 | 82,475,000 | 86,054,000 | 91,207,000 | 85,644,000 | 68,568,000 | 86,029,000 | 34,932,000 | 52,203,000 | 67,319,000 | 63,350,000 | 31,957,000 | 30,373,000 | 36,193,000 | 35,788,000 | 35,889,000 | 34,806,000 | 37,902,000 |
| stockholders' equity: | ||||||||||||||||||||||||||||||||
| common stock | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 2,000 | 2,000 | 2,000 | 2,000 | 1,000 |
| additional paid-in capital | 613,790,000 | 604,989,000 | 600,897,000 | 597,009,000 | 593,087,000 | 583,086,000 | 580,287,000 | 577,540,000 | 574,677,000 | 562,769,000 | 560,810,000 | 559,339,000 | 418,354,000 | 396,425,000 | 394,899,000 | 392,929,000 | 391,415,000 | 390,000,000 | 388,622,000 | 387,117,000 | 385,510,000 | 274,578,000 | 271,182,000 | 210,479,000 | 209,262,000 | 198,478,000 | 197,442,000 | 153,649,000 | 153,055,000 | 152,601,000 | 150,424,000 | 9,541,000 |
| accumulated deficit | -253,336,000 | -246,223,000 | -235,564,000 | -219,495,000 | -211,576,000 | -205,547,000 | -197,742,000 | -191,051,000 | -186,460,000 | -183,574,000 | -176,768,000 | -168,920,000 | -187,459,000 | -187,126,000 | -178,026,000 | -178,098,000 | -175,901,000 | -172,145,000 | -161,766,000 | -147,753,000 | -143,214,000 | -133,767,000 | -128,822,000 | -123,393,000 | -120,729,000 | -118,111,000 | -115,091,000 | -112,623,000 | -110,758,000 | -108,066,000 | -103,066,000 | -82,221,000 |
| accumulated other comprehensive loss | -4,946,000 | -11,626,000 | -10,773,000 | -6,601,000 | -10,224,000 | -6,961,000 | -5,526,000 | -12,166,000 | -7,911,000 | -6,046,000 | 161,000 | -1,361,000 | -3,000 | -985,000 | -455,000 | -322,000 | ||||||||||||||||
| total stockholders' equity | 355,514,000 | 347,146,000 | 354,566,000 | 370,919,000 | 371,293,000 | 370,584,000 | 377,025,000 | 374,329,000 | 380,312,000 | 373,155,000 | 378,648,000 | 383,330,000 | 227,216,000 | 215,044,000 | 225,369,000 | 221,118,000 | 221,601,000 | 222,145,000 | 234,768,000 | 239,436,000 | 242,462,000 | 139,267,000 | 142,361,000 | 86,105,000 | 88,082,000 | 80,049,000 | 81,732,000 | 40,685,000 | 42,057,000 | 44,754,000 | 47,495,000 | |
| total liabilities and stockholders' equity | 503,606,000 | 470,250,000 | 473,209,000 | 489,294,000 | 430,761,000 | 437,185,000 | 438,745,000 | 432,444,000 | 434,870,000 | 426,290,000 | 427,727,000 | 430,054,000 | 330,941,000 | 300,995,000 | 304,274,000 | 303,593,000 | 307,655,000 | 313,352,000 | 320,412,000 | 308,004,000 | 328,491,000 | 174,199,000 | 194,564,000 | 153,424,000 | 151,432,000 | 112,006,000 | 112,105,000 | 76,878,000 | 77,845,000 | 80,643,000 | ||
| accounts receivable - trade, net of allowances of 1,242 and 1,145, respectively | 43,993,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,145 and 1,373, respectively | 42,357,000 | |||||||||||||||||||||||||||||||
| commitments and contingencies | ||||||||||||||||||||||||||||||||
| cash and cash equivalents | 51,047,000 | 28,927,000 | 21,602,000 | 31,055,000 | 10,640,000 | 9,713,000 | 34,656,000 | 37,198,000 | 17,957,000 | 7,641,000 | 6,334,000 | 10,565,000 | 21,426,000 | 28,758,000 | ||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,025 and 1,373, respectively | 42,827,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,026 and 1,373, respectively | 42,028,000 | |||||||||||||||||||||||||||||||
| long-term debt, net of current portion | 9,250,000 | 9,579,000 | 9,297,000 | |||||||||||||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,195 and 1,373, respectively | 36,275,000 | |||||||||||||||||||||||||||||||
| short term investments | 49,251,000 | 109,299,000 | 84,710,000 | 13,963,000 | 27,068,000 | 45,902,000 | 51,349,000 | 55,288,000 | 55,209,000 | 55,141,000 | ||||||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,373 and 1,056, respectively | 34,617,000 | |||||||||||||||||||||||||||||||
| contingent consideration | 6,000 | 2,310,000 | 2,980,000 | 3,460,000 | 26,470,000 | 31,480,000 | 28,910,000 | 34,420,000 | 35,850,000 | 34,860,000 | 30,710,000 | 29,009,000 | 28,100,000 | |||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,412 and 1,056, respectively | 37,647,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, net of allowances of 1,097 and 1,056, respectively | 33,849,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, net of allowances of 942 and 1,056, respectively | 26,838,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 1,056 and 347, respectively | 24,800,000 | |||||||||||||||||||||||||||||||
| accumulated other comprehensive income | -5,400,000 | -7,095,000 | -3,684,000 | 5,740,000 | 8,491,000 | 6,282,000 | 6,082,000 | 4,285,000 | 7,907,000 | 67,000 | -623,000 | -343,000 | -242,000 | 217,000 | 135,000 | 193,000 | ||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 608 and 347, respectively | 26,184,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 412 and 347, respectively | 25,434,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 357 and 347, respectively | 17,911,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 347 and 433, respectively | 17,942,000 | |||||||||||||||||||||||||||||||
| notes receivable | 59,000 | 95,000 | 323,000 | 337,000 | 476,000 | 656,000 | 582,000 | 564,000 | 545,000 | 515,000 | 508,000 | 502,000 | ||||||||||||||||||||
| accrued legal settlements | 5,250,000 | 6,342,000 | ||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 373 and 433, respectively | 18,146,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 372 and 433, respectively | 19,222,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 361 and 433, respectively | 16,551,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 433 and 506, respectively | 17,212,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 208 and 506, respectively | 17,064,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 185 and 506, respectively | 14,897,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 176 and 506, respectively | 14,118,000 | |||||||||||||||||||||||||||||||
| treasury stock | -187,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 506 and 134, respectively | 16,003,000 | |||||||||||||||||||||||||||||||
| operating lease liabilities | 63,000 | 24,000 | ||||||||||||||||||||||||||||||
| deferred revenue | 12,410,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 365 and 134, respectively | 14,182,000 | |||||||||||||||||||||||||||||||
| current assets held for sale | 38,168,000 | 35,364,000 | ||||||||||||||||||||||||||||||
| short-term debt with affiliate | 30,000,000 | 30,000,000 | ||||||||||||||||||||||||||||||
| current liabilities held for sale | 3,085,000 | 494,000 | ||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 218 and 134, respectively | 14,974,000 | |||||||||||||||||||||||||||||||
| operating lease right-of-use asset | 75,000 | |||||||||||||||||||||||||||||||
| operating lease liabilities, net of current portion | 51,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 134 and 134, respectively | 10,296,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 134 and 143, respectively | 8,999,000 | |||||||||||||||||||||||||||||||
| inventories held by international distributors | 167,000 | 234,000 | 595,000 | 1,402,000 | 1,047,000 | 579,000 | ||||||||||||||||||||||||||
| revolving credit facility with affiliate | 3,947,000 | 3,938,000 | 3,930,000 | 3,921,000 | 7,500,000 | |||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 131 and 143, respectively | 9,456,000 | 9,755,000 | 6,838,000 | |||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 143 and 152, respectively | 5,603,000 | |||||||||||||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders' equity | ||||||||||||||||||||||||||||||||
| redeemable convertible preferred stock | ||||||||||||||||||||||||||||||||
| series a preferred stock, 0.00025 par value; 0 cumulative preferred dividends, december 31, 2017 and 7,439 december 31, 2016; 0 and 1,000,000 shares authorized, issued and outstanding as of december 31, 2017 and 2016, respectively | ||||||||||||||||||||||||||||||||
| series b preferred stock, 0.00025 par value; 0 cumulative preferred dividends, december 31, 2017 and 8,864 december 31, 2016; 0 and 6,000,000 shares authorized as of december 31, 2017 and 2016, respectively; 0 and 4,446,978 shares issued and outstanding as of december 31, 2017 and 2016, respectively | ||||||||||||||||||||||||||||||||
| stockholders' equity | ||||||||||||||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders' equity | 82,301,000 | |||||||||||||||||||||||||||||||
| accounts receivable - trade, less allowance for doubtful accounts of 148 and 152, respectively | 5,686,000 | |||||||||||||||||||||||||||||||
| deferred charges | 1,339,000 | |||||||||||||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders' deficit | ||||||||||||||||||||||||||||||||
| series a preferred stock, 0.00025 par value; 8,874 cumulative preferred dividends, september 30, 2017 and 7,439 december 31, 2016; 1,000,000 shares authorized, issued and outstanding | 24,874,000 | |||||||||||||||||||||||||||||||
| series b preferred stock, 0.00025 par value; 11,793 cumulative preferred dividends, september 30, 2017 and 8,864 december 31, 2016; 6,000,000 shares authorized; 4,446,978 shares issued and outstanding | 50,793,000 | |||||||||||||||||||||||||||||||
| stockholders' deficit: | ||||||||||||||||||||||||||||||||
| total stockholders' deficit | -72,486,000 | |||||||||||||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders' deficit | 41,083,000 | |||||||||||||||||||||||||||||||
| net revenue | 12,375,000 | |||||||||||||||||||||||||||||||
| cost of revenue | 2,884,000 | |||||||||||||||||||||||||||||||
| gross profit | 9,491,000 | |||||||||||||||||||||||||||||||
| operating expenses: | ||||||||||||||||||||||||||||||||
| sales and marketing | 5,633,000 | |||||||||||||||||||||||||||||||
| general and administrative | 3,487,000 | |||||||||||||||||||||||||||||||
| research and development | 1,127,000 | |||||||||||||||||||||||||||||||
| total operating expenses | 10,247,000 | |||||||||||||||||||||||||||||||
| operating income | -756,000 | |||||||||||||||||||||||||||||||
| other incomes: | ||||||||||||||||||||||||||||||||
| interest expense | 761,000 | |||||||||||||||||||||||||||||||
| other income | 20,000 | |||||||||||||||||||||||||||||||
| total other incomes | 781,000 | |||||||||||||||||||||||||||||||
| net income | -1,537,000 | |||||||||||||||||||||||||||||||
| net income attributable to common stockholders | -3,021,000 | |||||||||||||||||||||||||||||||
| weighted-average common shares - basic and diluted | 1,773,385,000 | |||||||||||||||||||||||||||||||
| net income per share | -1,700 |
We provide you with 20 years of balance sheets for OrthoPediatrics Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OrthoPediatrics Corp. Explore the full financial landscape of OrthoPediatrics Corp stock with our expertly curated balance sheets.
The information provided in this report about OrthoPediatrics Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.